An Observational Study of Inhaled-Treprostinil Respiratory-Related Safety in Patients with Pulmonary Arterial Hypertension
暂无分享,去创建一个
S. Mathai | E. Rosenzweig | R. Bourge | T. De Marco | D. Levine | C. Burger | A. Lim | R. Zamanian | H. Alnuaimat | N. Leedom | S. A. de Souza | K. DeAngelis
[1] J. Barberà,et al. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. , 2015, The New England journal of medicine.
[2] N. Hill,et al. Inhaled Therapies for Pulmonary Hypertension , 2015, Respiratory Care.
[3] M. Humbert,et al. The role of combination therapy in managing pulmonary arterial hypertension , 2014, European Respiratory Review.
[4] W. Seeger,et al. Updated treatment algorithm of pulmonary arterial hypertension. , 2013, Journal of the American College of Cardiology.
[5] E. Spiekerkoetter,et al. Current clinical management of pulmonary arterial hypertension. , 2014, Circulation research.
[6] M. Humbert,et al. Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study , 2014, European Respiratory Journal.
[7] W. Seeger,et al. Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[8] Horst Olschewski,et al. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. , 2010, Journal of the American College of Cardiology.
[9] H. Ghofrani,et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. , 2009, Journal of the American College of Cardiology.
[10] Jeffrey L. Anderson,et al. ACCF/AHA Expert Conseusus Document , 2009 .
[11] R. Barst,et al. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease. , 2007, The Journal of rheumatology.
[12] D. Badesch,et al. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. , 2007, Chest.
[13] R. Barst,et al. Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. , 2006, American journal of respiratory and critical care medicine.
[14] M. Hoeper,et al. Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension , 2006, European Respiratory Journal.
[15] R G Newcombe,et al. Confidence limits for the ratio of two rates based on likelihood scores: non-iterative method. , 2003, Statistics in medicine.
[16] Orris,et al. INHALED ILOPROST FOR SEVERE PULMONARY HYPERTENSION , 2002 .